Table 3 Distribution of pre-operative fine needle aspirate cytology and ddPCR mutation results in surgical specimen
Surgical Pathology | |||
|---|---|---|---|
Benign (%) | Malignant (%) | Total (%) | |
Cytology (Bethesday) | |||
I –Non- diagnostic | 19 (20.7) | 3 (3.2) | 22 (23.9) |
II - Benign | 30 (32.6) | 4 (4.3) | 34 (40.0) |
III – AUS/FLUS | 7 (7.6) | 4 (4.3) | 11 (12.0) |
IV – FN/SFN | 6 (6.5) | 0 | 6 (6.5) |
V - SFM | 0 | 4 (4.3) | 4 (6.5) |
VI- Malignant | 0 | 15 (16.3) | 15 (16.3) |
Mutations | |||
Low RNA | 2 (2.2) | 1 (1.1) | 3 (3.2) |
HRASG12 V | 14 (15.2) | 6 (6.5) | 20 (21.7) |
HRASQ61R | 14 (15.2) | 5 (5.4) | 19 (20.7) |
HRASQ61K | 8 (8.7) | 1 (1.1) | 9 (9.8) |
NRASQ61R | 6 (6.5) | 5 (5.4) | 11 (12.0) |
NRASQ61K | 3 (3.2) | 0 | 3 (3.2) |
BRAFV600E | 0 | 14 (15.2) | 14 (15.2) |